Fourrts India Laboratories Pvt Ltd, a generic drug manufacturer is setting up a unit in Vengadamangalam. 40 kms near Chennai with an investment of Rs. 400 million. It will manufacture new generation anti-diabetic drugs and cardiovascular drugs for developed countries. The new plant is built according to USFDA standards and European standards and likely to begin commercial production by April 2010. The company is also looking at contract manufacturing options